HR 4661 Missouri House · 2026 Regular Session

Encourages screening and treatment for kidney disease

This bill encourages the Missouri House of Representatives to promote screening and treatment for chronic kidney disease, which often goes undiagnosed and increases risks for heart attacks and strokes. It directs state health officials to explore public-private partnerships for educating patients and providers about urine tests that can detect early kidney damage, while also urging federal agencies to update guidelines for better cardiovascular-kidney screening access. The legislation focuses on improving early identification in primary care settings, particularly for at-risk groups like those with diabetes or hypertension, to slow disease progression and reduce long-term healthcare costs.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2026
Committee Review
Floor Vote
Governor
Introduced Mar 5, 2026 Last action May 4, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
10
Key actions
4
Committee
6
May 4, 2026
Lower · Passed
Reported Do Pass (H) - AYES: 9 NOES: 0 PRESENT: 0
lower
May 4, 2026
Lower · Passed
Voted Do Pass (H)
lower
Apr 30, 2026
Committee
Referred: Rules - Administrative(H)
lower
Apr 30, 2026
Lower · Passed
Reported Do Pass (H) - AYES: 15 NOES: 0 PRESENT: 0
lower
Apr 30, 2026
Lower · Passed
Voted Do Pass (H)
lower
Apr 7, 2026
Committee
Referred: Health and Mental Health(H)
lower
Mar 5, 2026
Introduced
Offered (H)
lower
1 primary · 1 co-sponsor

Sponsors